With the analysis among 4,998 patents, we discovered top 481 key players by total patent application. F. Hoffmann-La Roche Ltd., Sumitomo Chemical Co., Ltd., AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 12.34% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Sumitomo Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 124
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 123
Nordrhein-Westfalen, Germany
Patent: 105
New Jersey, United States
Patent: 67
Nordrhein-Westfalen, Germany
Patent: 48
Basel-Stadt, Switzerland
Patent: 48
New York, United States
Patent: 39
Hessen, Germany
Patent: 39
With the analysis among 103 patents, we discovered top 14 start-ups by total patent application. Endogena Therapeutics, Inc., BlackThorn Therapeutics, Inc., Chengdu Hyperway Pharmaceuticals Co., Ltd. are active in this area.
Endogena Therapeutics, Inc.
California, United States
Patent: 18
BlackThorn Therapeutics, Inc.
California, United States
Patent: 14
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 13
Institut National de la Santé et de la Recherche Médicale
Escient Pharmaceuticals, Inc.
California, United States
Patent: 12
Karnataka, India
Patent: 11
Autobahn Therapeutics, Inc.
California, United States
Patent: 11
California, United States
Patent: 3
California, United States
Patent: 2
With the analysis among related 1,588 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Bayer AG, Metys Pharmaceuticals AG, Zhejiang University take 9.38% of patent filing during this period.
Nordrhein-Westfalen, Germany
Patent: 68
Basel-Stadt, Switzerland
Patent: 48
Zhejiang Sheng, China
Patent: 33
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 32
F. Hoffmann-La Roche Ltd.
Berlin, Germany
Patent: 22
Shanghai SIMRD Biotechnology Co.,Ltd
Shanghai Simr Biotechnology Co Ltd
Shanghai Shi, China
Patent: 20
Nanjing Shijiang Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 19
Endogena Therapeutics, Inc.
California, United States
Patent: 18
With the analysis among related 1,588 patents in last 5 years, we discover 370 new entrants. Metys Pharmaceuticals AG, Shanghai Simr Biotechnology Co Ltd, Nanjing Shijiang Pharmaceutical Technology Co., Ltd. are the most active new entrants in this area.
Basel-Stadt, Switzerland
Patent: 48
Shanghai Simr Biotechnology Co Ltd
Shanghai Shi, China
Patent: 20
Nanjing Shijiang Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 19
Endogena Therapeutics, Inc.
California, United States
Patent: 18
Calithera Biosciences, Inc.
California, United States
Patent: 14
BlackThorn Therapeutics, Inc.
California, United States
Patent: 14
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 13
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 13
Escient Pharmaceuticals, Inc.
California, United States
Patent: 12
CONTRAF-NICOTEX-TOBACCO GmbH
With the analysis among 913 patents, we discovered top 227 universities and scientific research institutions by total patent application. Zhejiang University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Zhejiang University of Technology are dominant in this area. They take 13.36% of the total patent filing.
Zhejiang Sheng, China
Patent: 53
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 42
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 26
Council of Scientific & Industrial Research
Uniwersytet Przyrodniczy WE Wroclawiu
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 15
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 15
Pohang University of Science & Technology
Gyeongsangbuk-do, South Korea
Patent: 14
Sichuan Sheng, China
Patent: 13
East China University of Science & Technology
Shanghai Shi, China
Patent: 13